期刊文献+

环孢素联合沙利度胺治疗骨髓增生异常综合征的有效性及不良反应报告分析 被引量:4

下载PDF
导出
摘要 目的探究环孢素联合沙利度胺治疗骨髓增生异常综合征患者的效果以及不良反应。方法 100例骨髓增生异常综合征患者,随机分为实验组和对照组,每组50例。实验组给予环孢素A联合沙利度胺进行治疗,对照组仅给予沙利度胺进行治疗,对比两组临床效果及安全性。结果实验组治疗效果优于对照组(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论给予骨髓增生异常综合征患者环孢素A联合沙利度胺治疗,治疗效果较好,且具有较高的安全性。
作者 刘艳
出处 《中国实用医药》 2016年第12期130-131,共2页 China Practical Medicine
  • 相关文献

参考文献4

二级参考文献26

  • 1肖志坚.骨髓增生异常综合征:现况与问题[J].白血病.淋巴瘤,2005,14(4):193-196. 被引量:31
  • 2吴凌云,李晓,浦权.骨髓增生异常综合征的免疫治疗进展[J].新医学,2006,37(4):258-260. 被引量:11
  • 3徐泽锋,李睿,张莉,郝玉书,肖志坚.环孢素A单独或联合沙利度胺治疗骨髓增生异常综合征[J].中国实用内科杂志:临床前沿版,2006,26(10):1610-1612. 被引量:7
  • 4Cheson BD,Greenberg PL,Bennett JM,et al.Clinical application and proposal for modification of the International Working Croup (IWG) response criteria in myelodysplasia.Blood,2006,108:419-425.
  • 5Asano Y,Maeda M,Uchida N,et al.Immunosuppressive therapy for patients with refractory anemia.Ann Hematol,2001,80:634-638.
  • 6Dixit A,Chatterjee T,Mishra P,et al.Cyclosporin A in myelodys-plastic syndrome:a preliminary report.Ann Hematol,2005,84:565-568.
  • 7Moreno-Aspitia A,Geyer S,Li CY,et al.N998B:multicenter phase Ⅱ trial of thalidomide in adult patients with myelodysplastic syndromes.Blood,2002,100:96a.
  • 8Musto P,Falcone A,Sanpaolo G,et al.Thalidomide abolishes ransfusion-dependence in selected patients with myelodysplastic syndromes.Haematologica,2002,87:884-886.
  • 9Bouscary D,Legros L,Tulliez M,et al.A non-randomised dose-escalating phase Ⅱ study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes:the Thal-SMD-2000 trial of the Groupe Franccais des My(e)lodysplasies.Br J Haematol,2005,131:609-618.
  • 10Tamburini J,Elie C,Park S,et al.Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes.Leuk Res,2009,33:547-550.

共引文献19

同被引文献34

  • 1Hussein AA,Halkes CM,SociéG,et al.Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia:a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation[J].Biol Blood Marrow Transplant,2014,20(9):1448-1450.
  • 2Tichelli A,Marsh JC.Treatment of aplastic anaemia in elderly patients aged>60 years[J].Bone Marrow Transplant,2013,48(2):180-182.
  • 3Shin SH,Lee SE,Lee JW.Recent advances in treatment of aplastic anemia[J].Korean J Intern Med,2014,29(6):713-726.
  • 4Keeli SA,Willke A,Tamer GS,et al.Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods[J].APMIS,2014,122(5):412-417.
  • 5Laishram S,Anandan S,Devi BY,et al.Determination of synergy between sulbactam,meropenem and colistin in carbapenemresistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance[J].J Chemother,2015,2:1973947815Y0000000079.
  • 6Shortt J,Hsu AK,Johnstone RW.Thalidomide-analogue biology:immunological,molecular and epigenetic targets in cancer therapy[J].Oncogene,2013,32(36):4191-4202.
  • 7刘昀,吴长有.Th22细胞的研究进展[J].中国免疫学杂志,2010,26(4):372-374. 被引量:11
  • 8何广胜,吴德沛,孙爱宁,梁建英,刘丹丹,陈子兴,薛永权,阮长耿.WHO 2008年骨髓增生异常综合征诊断与分型修订解读[J].中国实用内科杂志,2010,30(5):416-421. 被引量:43
  • 9徐泽锋,秦铁军,张悦,刘凯奇,郝玉书,肖志坚.环孢素联合沙利度胺治疗骨髓增生异常综合征[J].中华血液学杂志,2010,31(7):451-455. 被引量:15
  • 10张学军.环孢素联合沙利度胺治疗骨髓增生异常综合征[J].当代医学,2011,17(3):134-135. 被引量:3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部